A case study of venous leg ulceration

British Journal of Community Nursing
Michelle Porter

Abstract

Venous ulcers or stasis ulcers account for 80% of lower extremity ulcerations. Approximately 1-2% of the population will suffer from the chronic debilitating condition, with chronic venous insufficiency affecting up to 50% of the adult population. There are many methods of treatment and common treatments include conventional, surgical or mechanical methods. This article examines the complications of leg ulcer management, with the emphasis on the use of antibiotics. The case study demonstrates the positive impact self-care can have as part of a treatment plan.

References

Nov 1, 1994·Journal of Vascular Surgery·A Abu-OwnP D Coleridge Smith
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·G SiamiUNKNOWN Severe Skin and Soft Tissue Infections Study Group
Apr 9, 2001·Clinical Microbiology Reviews·P G BowlerD G Armstrong
Jan 15, 2005·The Journal of Antimicrobial Chemotherapy·R S Howell-JonesD W Thomas
Jun 9, 2005·International Journal of Dermatology·Luciana P Fernandes Abbade, Sidnei Lastória
Feb 6, 2007·Clinics in Dermatology·Chukwuemeka N Etufugh, Tania J Phillips

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.